In DCs, Tim-3 inhibits its activation and maturation by blocking NF-κB signaling via a Btk-c-Src signaling-dependent mechanism, interfering with the ability of cytoplasmic toll-like receptors (TLRs) to sense immunogenicity and thereby suppressing anti-tumor immunity [83]. The gene discussed is HAVCR2; the disease is neoplasm.